Literature DB >> 19439533

Diversity of group B streptococcus serotypes causing urinary tract infection in adults.

Kimberly B Ulett1, William H Benjamin, Fenglin Zhuo, Meng Xiao, Fanrong Kong, Gwendolyn L Gilbert, Mark A Schembri, Glen C Ulett.   

Abstract

Serotypes of group B streptococcus (GBS) that cause urinary tract infection (UTI) are poorly characterized. We conducted a prospective study of GBS UTI in adults to define the clinical and microbiological characteristics of these infections, including which serotypes cause disease. Patients who had GBS cultured from urine over a 1-year period were grouped according to symptoms, bacteriuria, and urinalysis. Demographic data were obtained by reviewing medical records. Isolates were serotyped by latex agglutination and multiplex PCR-reverse line blotting (mPCR/RLB). Antibiotic susceptibilities were determined by disc diffusion. GBS was cultured from 387/34,367 consecutive urine samples (1.1%): 62 patients had bacteriuria of >10(7) CFU/liter and at least one UTI symptom; of these patients, 31 had urinary leukocyte esterase and pyuria (others not tested), 50 (81%) had symptoms consistent with cystitis, and 12 (19%) had symptoms of pyelonephritis. Compared with controls (who had GBS isolated without symptoms), a prior history of UTI was an independent risk factor for disease. Increased age was also significantly associated with acute infection. Serotyping results were consistent between latex agglutination and mPCR/RLB for 331/387 (85.5%) isolates; 22 (5.7%) and 7 (1.8%) isolates were nontypeable with antisera and by mPCR/RLB, respectively; and 45/56 (80.4%) isolates with discrepant results were typed by mPCR/RLB as belonging to serotype V. Serotypes V, Ia, and III caused the most UTIs; serotypes II, Ib, and IV were less common. Nontypeable GBS was not associated with UTI. Erythromycin (39.5%) and clindamycin (26.4%) resistance was common. We conclude that a more diverse spectrum of GBS serotypes causes UTI than previously recognized, with the exception of nontypeable GBS.

Entities:  

Mesh:

Year:  2009        PMID: 19439533      PMCID: PMC2708523          DOI: 10.1128/JCM.00154-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

1.  Simultaneous detection and serotype identification of Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization.

Authors:  Fanrong Kong; Lin Ma; Gwendolyn L Gilbert
Journal:  J Med Microbiol       Date:  2005-12       Impact factor: 2.472

Review 2.  Morbidity related to maternal group B streptococcal infections.

Authors:  Anouk E Muller; Paul M Oostvogel; Eric A P Steegers; P Joep Dörr
Journal:  Acta Obstet Gynecol Scand       Date:  2006       Impact factor: 3.636

3.  Serotype identification of group B streptococci by PCR and sequencing.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 4.  Does this woman have an acute uncomplicated urinary tract infection?

Authors:  Stephen Bent; Brahmajee K Nallamothu; David L Simel; Stephan D Fihn; Sanjay Saint
Journal:  JAMA       Date:  2002 May 22-29       Impact factor: 56.272

5.  A composite transposon associated with erythromycin and clindamycin resistance in group B Streptococcus.

Authors:  Karen M Puopolo; David C Klinzing; Michelle P Lin; Derek L Yesucevitz; Michael J Cieslewicz
Journal:  J Med Microbiol       Date:  2007-07       Impact factor: 2.472

6.  Streptococcus agalactiae infections in non-pregnant adults: single center experience of a growing clinical problem.

Authors:  Matthew E Falagas; Evangelos S Rosmarakis; Iraklis Avramopoulos; Nikolaos Vakalis
Journal:  Med Sci Monit       Date:  2006-11

Review 7.  Group B streptococcal infections in elderly adults.

Authors:  Morven S Edwards; Carol J Baker
Journal:  Clin Infect Dis       Date:  2005-08-16       Impact factor: 9.079

8.  Low colony counts of asymptomatic group B streptococcus bacteriuria: a survey of practice patterns.

Authors:  Matthew Aungst; Jeremy King; Andrew Steele; Michael Gordon
Journal:  Am J Perinatol       Date:  2004-10       Impact factor: 1.862

Review 9.  Urinary tract infections during pregnancy.

Authors:  Jennifer Le; Gerald G Briggs; Anna McKeown; Gerardo Bustillo
Journal:  Ann Pharmacother       Date:  2004-08-31       Impact factor: 3.154

10.  The international infections in pregnancy study: group B streptococcal colonization in pregnant women.

Authors:  C G Whitney; S Daly; S Limpongsanurak; M R Festin; K K Thinn; T Chipato; P Lumbiganon; J Sauvarin; W Andrews; J E Tolosa
Journal:  J Matern Fetal Neonatal Med       Date:  2004-04
View more
  30 in total

1.  Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.

Authors:  Chee K Tan; Alison J Carey; Xiangqin Cui; Richard I Webb; Deepak Ipe; Michael Crowley; Allan W Cripps; William H Benjamin; Kimberly B Ulett; Mark A Schembri; Glen C Ulett
Journal:  Infect Immun       Date:  2012-06-25       Impact factor: 3.441

2.  Phylogenetic lineage and pilus protein Spb1/SAN1518 affect opsonin-independent phagocytosis and intracellular survival of Group B Streptococcus.

Authors:  Debasish Chattopadhyay; Alison J Carey; Elise Caliot; Richard I Webb; James R Layton; Yan Wang; John F Bohnsack; Elisabeth E Adderson; Glen C Ulett
Journal:  Microbes Infect       Date:  2011-01-14       Impact factor: 2.700

3.  Mechanisms of and risk factors for fluoroquinolone resistance in clinical Enterococcus faecalis isolates from patients with urinary tract infections.

Authors:  Tomihiko Yasufuku; Katsumi Shigemura; Toshiro Shirakawa; Minori Matsumoto; Yuzo Nakano; Kazushi Tanaka; Soichi Arakawa; Masato Kawabata; Masato Fujisawa
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

4.  Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection.

Authors:  Kimberly A Kline; Drew J Schwartz; Warren G Lewis; Scott J Hultgren; Amanda L Lewis
Journal:  Infect Immun       Date:  2011-06-20       Impact factor: 3.441

5.  A Murine Model of Group B Streptococcus Vaginal Colonization.

Authors:  Kathryn A Patras; Kelly S Doran
Journal:  J Vis Exp       Date:  2016-11-16       Impact factor: 1.355

6.  Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea.

Authors:  M Ki; U Srinivasan; K Y Oh; M Y Kim; J-H Shin; H L Hong; T Dang; Z Britt; B Foxman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-04       Impact factor: 3.267

7.  Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.

Authors:  Kimberly A Kline; Drew J Schwartz; Nicole M Gilbert; Scott J Hultgren; Amanda L Lewis
Journal:  Infect Immun       Date:  2012-09-17       Impact factor: 3.441

Review 8.  Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract.

Authors:  Kimberly A Kline; Amanda L Lewis
Journal:  Microbiol Spectr       Date:  2016-04

9.  Discovery and Characterization of Human-Urine Utilization by Asymptomatic-Bacteriuria-Causing Streptococcus agalactiae.

Authors:  Deepak S Ipe; Nouri L Ben Zakour; Matthew J Sullivan; Scott A Beatson; Kimberly B Ulett; William H Benjamin; Mark R Davies; Samantha J Dando; Nathan P King; Allan W Cripps; Mark A Schembri; Gordon Dougan; Glen C Ulett
Journal:  Infect Immun       Date:  2015-11-09       Impact factor: 3.441

Review 10.  Group B streptococcal infection of the genitourinary tract in pregnant and non-pregnant patients with diabetes mellitus: An immunocompromised host or something more?

Authors:  Lynsa M Nguyen; Joel I Omage; Kristen Noble; Kelsey L McNew; Daniel J Moore; David M Aronoff; Ryan S Doster
Journal:  Am J Reprod Immunol       Date:  2021-10-19       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.